Association of GLP1-Receptor Agonist Use With Frailty and Falls in Adults With Type 2 Diabetes.
OBJECTIVE To evaluate the association of initiating glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors (as active comparator) with frailty progression and falls and whether associations differed by baseline frailty. RESEARCH DESIGN AND METHODS Five propensity score-matched retrospectiv...